Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
51 Cards in this Set
- Front
- Back
Classic signs for cystitis
|
Suprapubic tenderness
Dysuria Frequency Urgency |
|
Location of initial pain in appendicitis
|
Periumbilical
|
|
3 enteric organisms that ferment lactose
|
E. coli
Enterobacter Klebsiella |
|
Mottling of tooth enamel
|
Tetracyclines side effect when used in children under 8 or in pregnant women
|
|
Verruca vulgaris
|
Common wart
Benign papilloma HPV |
|
Glomerulonephritis
Findings? |
Hematuria
Red cell casts Oliguria Azotemia Hypertension |
|
Pelvic inflammatory disease
|
Severe lower abdominal pain
Fever Purulent cervical discharge Cervical motion tenderness |
|
Fluoroquinolones
|
Ciprofloxacin
Norfloxacin Moxifloxacin |
|
Fluoroquinolones MoA
|
Inhibit DNA gyrase (topoisomerase II)
|
|
Fluoroquinolones indications
|
Gram-negative rods of urinary and gi tracts
|
|
Fluoroquinolones toxicities
|
Damage to cartilage in fetus and children
Tendonitis and tendon rupture in adults |
|
1st generation cephalosporins agents and clinical use
|
Cefazolin
Cephalexin Gram-Positive cocci: Proteus mirabilis E. coli Klebsiella penumoniae PEcK |
|
2nd generation cephalosporins agents and clinical use
|
Agents:
Cefoxitin Cefaclor Cefuroxime Use: Gram-positive cocci Haemophilus influenzae Enterobacter aerogenes Neisseria spp Proteus mirabilis E. coli K. pneumoniae Serratia marcescens HEN PEcKS |
|
3rd generation cephalosporins agents and clinical use
|
Ceftriaxone
Cefotaxime Ceftazidime Use: Gram-negative resistant to other B-lactams; meningitis |
|
4th generation cephalosporins agents and clinical use
|
Cefepime
Cefpiramide Incr activity against Pseudomonas and gram-positive organisms |
|
Hairy leukoplakia
|
Fuzzy white tongue in some AIDS patients
|
|
Which anemia does lead toxicity lead to?
|
Microcytic Hypochromic
Resembles iron deficiency anemia |
|
Which enzymes does lead interfere with in the synthesis of heme?
|
Ferrochelatase
|
|
RBC appearance in hereditary spherocytosis
|
Small spheres
Lack biconcave shape |
|
Basophilic stippling
|
Precipitated ribosomes and mitochondria
Impaired maturation in the bone marrow Roudn, dark-blue granules in RBCs |
|
Acanthocytes
|
Star-like RBCs
Irregular spaced projections Abetalipoproteinemia Some liver diseases |
|
Auer rods
|
Elongated, bluish-red rods
Fused lysosomal granules Found in the cytoplasm of cells in the myelocytic and monoblastic lines Acute Myelogenous Leukemia |
|
Hairy cells
|
Hairy cell leukemia
White cells with fine, irregular pseudopods, and immature nuclear features |
|
Sulfasalazine clinical use
|
Rheumatoid arthritis
|
|
Tolbutamide
|
Sulfonylurea
Oral hypoglycemic agent |
|
Most common cause of sensorineural hearing loss in adults
|
Acoustic neuroma (schwanoma)
|
|
Cholesteatomas
|
Epidermoid inclusion cysts
Middle ear and petrous apex Intermittent drainage Conductive hearing loss |
|
Air conduction vs bone conduction
Normal |
Normal:
Air conduction is greater than bone conduction |
|
Sensorineural hearing loss:
Air conduction vs bone conduction |
Air conduction is greater than bone conduction, both will be qualitatively decreased
|
|
Weber test
|
In unilateral sensorineural hearing loss the sound is softer on the affected side and is loder (localized) to the unaffected ear
|
|
Antibiotic block protein synthesis at 30S riborsomal subunit
|
Aminoglycosides
Tetracyclines |
|
Antibiotics that block protein synthesis at 50S ribosomal subunit
|
Chloramphenicol
Clindamycin Lincomycin Linezolid Erythromycin/Macrolides Streptogramins (Quinupristin, dalfopristin) |
|
Antibiotic block DNA topoisomerases
|
Quinolones
|
|
Protein synthesis inhibitors
|
30S inhibitors
Aminoglycosides: (streptomycin, gentamicin, tobramycin, amikacin)[bactericidal] Tetracyclines [bacteriostatic] 50S inhibitors Chloramphenicol [bacteriostatic] Erythromycin [bacteriostatic] Lincomycin [bacteriostatic] cLindamycin [bacteriostatic] buy AT 30, CELL at 50 |
|
V/Q ---> 0 = ?
|
Airway obstruction (shunt)
|
|
V/Q ---> infinity = ?
|
Blood flow obstruction (physiologic dead space)
|
|
V/Q mismatch
|
Ideally, ventilation is matched to perfusion (V/Q = 1) in order for adequet gas exchange
|
|
V/Q at the apex of the lungs
|
V/Q = 3 (wasted ventilation)
|
|
V/Q at the base of the lungs
|
V/Q = 0.6 (wasted perfusion)
|
|
V/Q
Apex vs Base of the lungs |
Both are greater at the base of the lungs
|
|
Spherocytosis treatment
|
Splenectomy
|
|
Class IA antiarrhythmic agents
|
Quinidine
Amiodarone Procainamide Disopyramid |
|
Class IA antiarrhythmic effect
|
Increase AP duration
Increase effective refractory period (ERP) Increase QT interval Affect both atrial and ventricular arrhythmias |
|
Class IB antiarrhythmic agents
|
Lidocaine
Mexiletine Tocainide |
|
Class IB antiarrhythmic agents effect
|
Decrease AP duration
Affect ischemic or depolarized Purkinje and ventricular tissue |
|
Class IB antiarrhythmic agents use
|
Acute ventricular arrhythmias (especially post-MI) and in digitalis-induced arrhythmias
|
|
Class IA antiarrhythmic agents toxicity
|
Quinidine:
Cinchonism (headache, tinnitus) Thrombocytopenia, Torsades de pointes (due to increased QT interval) Procainamide: Reversible SLE-like syndrome |
|
Class IC antiarrhythmic agents
|
Flecainide
Encainide Propafenone |
|
Class IC antiarrhythmic effect
|
No effect on AP duration
V-tachs that progress to VF and in intractible SVT |
|
Class IC antiarrhythmic agents use
|
Last resort in refractory tachyarrhythmias
|
|
Class IC antiarrhythmic agents toxicity
|
Proarrhythmic (especially post-MI [contraindicated])
|